Latest Pharmaceuticals News

Page 20 of 63
Starpharma’s 2025 AGM highlighted breakthrough partnerships and clinical progress, positioning the biotech for growth. Key deals with Genentech and Radiopharm Theranostics underpin a promising pipeline and expanding revenue streams.
Ada Torres
Ada Torres
14 Nov 2025
Biotron Limited’s lead HBV drug BIT-HBV001 demonstrates superior antiviral activity and synergy with the current standard treatment Tenofovir in preclinical models, advancing hopes for a more effective Hepatitis B therapy.
Ada Torres
Ada Torres
14 Nov 2025
The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.
Ada Torres
Ada Torres
13 Nov 2025
Island Pharmaceuticals will host a webinar to discuss the FDA's feedback on the clinical development and regulatory approval of its antiviral drug Galidesivir, including key considerations under the FDA's Animal Rule and Priority Review Voucher eligibility.
Ada Torres
Ada Torres
13 Nov 2025
EBOS Group Limited has updated its Dividend Reinvestment Plan rules, offering shareholders new ways to reinvest dividends into additional shares. The changes, effective immediately, provide greater flexibility and maintain board discretion over share issuance terms.
Ada Torres
Ada Torres
13 Nov 2025
The FDA's removal of the black box warning on hormone replacement therapies marks a pivotal shift for Mayne Pharma, potentially unlocking new market opportunities and reshaping women’s health treatment.
Victor Sage
Victor Sage
12 Nov 2025
Pathkey.AI has teamed up with Armstrong Clinical to blend AI-driven trial predictions with expert clinical strategy, aiming to boost early-phase trial success and accelerate drug development in Australia and beyond.
Ada Torres
Ada Torres
12 Nov 2025
Savana Asset Management’s new white paper confirms its algorithmic valuation model can systematically exploit market inefficiencies, highlighted by Canadian Solar’s recent 120% rally and a potential $12 trillion US capex surge.
Claire Turing
Claire Turing
11 Nov 2025
Cann Group Limited has finalized a $15.3 million settlement with National Australia Bank, releasing all security and closing loan facilities as part of a broader debt restructuring. The company is advancing a $9 million new loan and a $9 million capital raise, including a share purchase plan closing November 17.
Ada Torres
Ada Torres
11 Nov 2025
Mayne Pharma has received notice of Cosette Pharmaceuticals' intention to appeal a court ruling in their acquisition dispute, potentially delaying the proposed takeover. The legal saga continues as key approvals and hearings loom.
Victor Sage
Victor Sage
10 Nov 2025
Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.
Ada Torres
Ada Torres
10 Nov 2025
Algorae Pharmaceuticals has launched AlgoraeOS Version 2, a major AI platform upgrade that surpasses leading models including those from Google DeepMind, promising to accelerate drug-combination discovery.
Ada Torres
Ada Torres
10 Nov 2025